Home
Conditions
Urinary Bladder Diseases

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,285 public trials 413 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Active, Not Recruiting

Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

NCT06307704

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +18 more
Locations: Cairo University Hospitals Cairo, Egypt

View Trial Details

Active, Not Recruiting

A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630

NCT05055050

Conditions: Bladder, Bladder Cancer, Female Urogenital Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence

NCT05534412

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
Locations: University of California, San Diego La Jolla, California, United States

Cedars-Sinai Los Angeles, California, United States

University of California, Los Angeles Los Angeles, California, United States

Harbor-UCLA Medical Center Torrance, California, United States

View Trial Details

Active, Not Recruiting

Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma

NCT04004442

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
Locations: Stephenson Cancer Center Oklahoma City, Oklahoma, United States

View Trial Details

Active, Not Recruiting

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

NCT01295645

Conditions: Cystitis, Cystitis, Hemorrhagic, Female Urogenital Diseases, +10 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

NCT04940299

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

NCT02675829

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Active, Not Recruiting

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

NCT04848519

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +30 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions: Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations: Research Site Boston, Massachusetts, United States

Research Site Boston, Massachusetts, United States

Research Site New York, United States

Research Site Oklahoma City, Oklahoma, United States

View all 68 locations

View Trial Details

Active, Not Recruiting

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

NCT05137262

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: Indiana University Bloomington, Indiana, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Urinary Bladder Diseases

Urinary Bladder Diseases trial results

Related conditions